Effects of Genistein in Postmenopausal Women With Metabolic Syndrome
Role of Genistein on Metabolic Syndrome in Post-menopausal Women
Sponsor: Ministry of Education, Universities and Research, Italy
A PHASE2/PHASE3 clinical study on Metabolic Syndrome, this trial is completed. The trial is conducted by Ministry of Education, Universities and Research, Italy and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ministry of Education, Universities and Research, Italy
- University of Messina
For direct contact, visit the study record on ClinicalTrials.gov .